ROSELLI, MARIO

ROSELLI, MARIO  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 20 di 234 (tempo di esecuzione: 0.035 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2002 [Ductal carcinoma in situ (DCIS): an always present reality; which treatment? Role of sentinel lymph node] Buonomo, Oc; Granai, A; Piccirillo, R; Felici, A; Cossu, E; Cipriani, C; Casciani, C; Roselli, M Articolo su rivista
1-gen-2012 A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes Palmirotta, R; Ludovici, G; De Marchis, M; Leone, B; Formica, V; Ettorre, G; Cavaliere, F; DELLA MORTE, D; Ferroni, P; Roselli, M; Guadagni, F Articolo su rivista
1-gen-2019 A nomogram to predict neutropenia in metastatic pancreatic cancer patients treated with gemcitabine/nab-paclitaxel Morelli, C; Formica, V; Nardecchia, A; Lucchetti, J; Tisone, G; Anselmo, A; Del Vecchio Blanco, G; Benassi, M; Palmieri, G; Argiro, R; Roselli, M Articolo su rivista
1-ago-2009 A novel K-ras mutation in colorectal cancer. A case report and literature review Palmirotta, R; Savonarola, A; Formica, V; Ludovici, G; Del Monte, G; Roselli, M; Guadagni, F Articolo su rivista
1-gen-2016 A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer Curigliano, G; Romieu, G; Campone, M; Dorval, T; Duck, L; Canon, J; Roemer Becuwe, C; Roselli, M; Neciosup, S; Burny, W; Callegaro, A; de Sousa Alves, P; Louahed, J; Brichard, V; Lehmann, F Articolo su rivista
1-gen-2014 A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice Barni, S; Lorusso, V; Giordano, M; Sogno, G; Gamucci, T; Santoro, A; Passalacqua, R; Iaffaioli, V; Zilembo, N; Mencoboni, M; Roselli, M; Pappagallo, G; Pronzato, P Articolo su rivista
1-ago-2001 A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study Guadagni, F; Ferroni, P; Carlini, S; Mariotti, S; Spila, A; Aloe, S; D'Alessandro, R; Carone, M; Cicchetti, A; Ricciotti, A; Venturo, I; Perri, P; Di Filippo, F; Cognetti, F; Botti, C; Roselli, M Articolo su rivista
1-set-2021 A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attention Iannantuono, Gm; Strigari, L; Roselli, M; Torino, F Articolo su rivista
1-gen-2021 A systematic review and meta-analysis of PD-1/PD-L1 inhibitors in specific patient subgroups with advanced gastro-oesophageal junction and gastric adenocarcinoma Formica, V; Morelli, C; Patrikidou, A; Shiu, Kk; Nardecchia, A; Lucchetti, J; Roselli, M; Arkenau, Ht Articolo su rivista
3-apr-2022 Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review Iannantuono, Gm; Riondino, S; Sganga, S; Roselli, M; Torino, F Articolo su rivista
1-gen-2001 Adjuvant chemotherapy for stage IB non-small cell lung cancer Ambrogi, V; Mariotti, S; Roselli, M; Mineo, Tc Intervento a convegno
1-ago-2013 Aging: an important risk factor in chemotherapy-associated vascular diseases Roselli, M; Guadagni, F; Ferroni, P Articolo su rivista
1-mag-2011 An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients Ferroni, P; Martini, F; Portarena, I; Grenga, I; Riondino, S; La Farina, F; Laudisi, A; Roselli, M; Guadagni, F Articolo su rivista
1-ott-2013 An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies Palmirotta, R; Leone, B; De Marchis, M; Ludovici, G; Savonarola, A; Ferroni, P; Rundek, T; Roselli, M; DELLA MORTE, D; Guadagni, F Articolo su rivista
1-feb-2012 An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy Grünwald, V; Karakiewicz, P; Bavbek, S; Miller, K; Machiels, J; Lee, S; Larkin, J; Bono, P; Rha, S; Castellano, D; Blank, C; Knox, J; Hawkins, R; Anak, O; Rosamilia, M; Booth, J; Pirotta, N; Bodrogi, I; Romedi, M; Ferrandini, S; Rondinon, M; Pittman, K; Goldstein, D; Shapiro, J; Troon, S; Yip, D; Mainwaring, P; Zigeuner, R; Loidl, W; Greil, R; Schmidinger, M; De Grève, J; Rottey, S; Vermorken, J; Machiels, J; Gil, T; Gennigens, C; Roumeguere, T; Barrios, C; Mathias, C; Assi, H; Hotte, S; Karakiewicz, P; Knox, J; Spadafora, S; Wood, L; Zalewski, P; Mackensie, M; Bjarnason, G; Lalancette, A; Chan, A; Higgins, B; North, S; Soulieres, D; Asselah, J; Sperlich, C; Miller, W; Yadav, S; El Maraghi, R; Godoy, J; Prausová, J; Katolicka, J; Petruzelka, L; Kiss, I; Bono, P; Lapela, M; Miller, K; Grünwald, V; Bergmann, L; Beck, J; Jäger, E; Kindler, M; Overkamp, F; Wirth, M; Hölzer, W; Gschwend, J; Stenzl, A; Gauler, T; Niederwieser, D; Marschner, N; Lück, A; Tessen, H; Eichelberg, C; Steiner, T; Goebell, P; Kettner, E; Bakhshandeh Bath, A; Wilhelm, M; Schmitz, S; Jacob, A; Bierer, S; Kube, U; Staehler, M; Engel, E; Frambach, M; Schellenberger, U; Albers, P; Simon, J; Gleissler, M; Klotz, T; Repp, R; Kröning, H; Westermann, J; Rebmann, U; Brehmer, B; Niederle, N; Grund, C; Verpoort, K; Fonara, P; Rassweiler, J; Bamias, A; Fountzilas, G; Razis, E; Mouratidou, D; Georgoulias, V; Samantas, E; Bodrogi, I; Mangel, L; Szanto, J; Berger, R; Pe'Er, A; Sella, A; Ben Yosef, R; Nechushtan, H; Crinò, L; Bracarda, S; Ciuffreda, L; Graiff, C; Falcone, A; Roselli, M; Sternberg, C; Santoro, A; Ruggeri, E; Bearz, A; Venturini, M; Aglietta, M; Amadori, D; Di Costanzo, F; Bari, M; Gebbia, N; Conte, P; Bonetti, A; Bordonaro, R; Cascinu, S; Contu, A; Cruciani, G; Gasparro, D; Nardi, M; Lelli, G; Lo Re, G; Boccardo, F; Lorusso, V; Maiello, E; Manente, P; Passalacqua, R; Piantedosi, F; Porta, C; Sacco, C; Tondini, C; De Placido, S; Carteni, G; Dogliotto, L; Rosti, G; Milella, M; Roila, F; Amoroso, D; Farina, G; Al Khatib, H; Lee, S; Kim, T; Ahn, J; Lim, H; Rha, S; Chung, I; Kim, J; Chung, J; Ghosn, M; Shameseddine, A; Lugo, R; Cabrera, P; Osanto, S; Groenewegen, G; Blank, C; van den Eertwegh, F; van Herpen, C; Oosting, S; Soetekouw, P; Lilleby, W; Klepp, O; Guren, T; Alcedo, J; Karlov, P; Nosov, D; Roman, L; Rusakov, I; Bazarbashi, S; Toh, C; Mardiak, J; del Muro Solans, F; Ray, J; Mollins, J; Castellano, D; Martinez, I; Gonzalez, B; Santasusana, M; Piqueras, M; Fuentes, J; Larriba, J; Caro, R; Garcia, A; Aparicio, L; Lopez, N; Aragon, V; Morales, C; Figueiras, M; Ibanez, J; Billalabeitia, G; Estrada, E; Arranz, J; Sorrosal, J; Lozano, A; de Villena, M; Espinosa, E; Lopez, R; Perez, J; Laurell, A; Stierner, U; Cwikiel, M; Borner, M; Dietrich, P; Rothermundt, C; Pu, Y; Chang, Y; Ou, Y; Chuang, C; Liao, Y; Srimuninnimit, V; Sriuranpong, V; Bavbek, S; Buyukberber, S; Yalcin, B; Goker, E; Yalcin, S; Geldart, T; Wagstaff, J; Nicholson, S; Chowdhury, S; Bahl, A; Jones, R; Azzabi, A; Chao, D; Fife, K; Hawkins, R; Larkin, J; Mead, G; Nathan, P; Pandha, H; Hajdenberg, J; Gabrail, N; Nimeh, N; Logan, T; Flaig, T; Schraeder, R; Rini, B; O'Rourke, M; Alemany, C; Beck, J; Kessinger, A; Amin, A; Arriaga, M; Rodriguez, J Articolo su rivista
1-lug-2012 Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies Ferroni, P; DELLA MORTE, D; Palmirotta, R; Rundek, T; Guadagni, F; Roselli, M Articolo su rivista
1-gen-2017 Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer Riondino, S; Del Monte, G; Fratangeli, F; Guadagni, F; Roselli, M; Ferroni, P Articolo su rivista
1-gen-2018 Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis Grenga, I; Donahue, Rn; Gargulak, Ml; Lepone, Lm; Roselli, M; Bilusic, M; Schlom, J Articolo su rivista
30-ago-2023 Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives Sganga, S; Riondino, S; Iannantuono, Gm; Rosenfeld, R; Roselli, M; Torino, F Articolo su rivista
1-gen-2023 Applications of large language models in cancer care: current evidence and future perspectives Iannantuono, Gm; Bracken-Clarke, D; Floudas, Cs; Roselli, M; Gulley, Jl; Karzai, F Articolo su rivista